Profile
Philip A. van Damme is the founder who has founded Stichting Sanammad in 2009 and Sanammad Pharmaceuticals BV in 2014, where he holds the title of President & Director.
He was also a former Director, Chief Scientific & Medical Officer at AXIM Biotechnologies, Inc. from 2014 to 2020 and a former Director at CanChew Biotechnologies LLC from 2012 to 2013.
Dr. van Damme earned a doctorate degree from the University of Utrecht in 1983.
Philip A. van Damme active positions
| Companies | Position | Start |
|---|---|---|
Stichting Sanammad
Stichting Sanammad Investment Trusts/Mutual FundsMiscellaneous Operates as a medical and research and development organization | Founder | 2008-12-31 |
Sanammad Pharmaceuticals BV | Founder | 2013-12-31 |
Former positions of Philip A. van Damme
| Companies | Position | End |
|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2020-05-05 |
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology Manufactures cannabis-based medicinal products and provides medical research and development services | Chief Tech/Sci/R&D Officer | - |
Training of Philip A. van Damme
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AXIM Biotechnologies, Inc.
AXIM Biotechnologies, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceuticals | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology Manufactures cannabis-based medicinal products and provides medical research and development services | Health Technology |
Stichting Sanammad
Stichting Sanammad Investment Trusts/Mutual FundsMiscellaneous Operates as a medical and research and development organization | Miscellaneous |
Sanammad Pharmaceuticals BV |
- Stock Market
- Insiders
- Philip A. van Damme
















